The University of Chicago Header Logo

Sean Pitroda

Concepts (317)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
37
2024
3037
3.230
Why?
Carcinoma, Non-Small-Cell Lung
10
2024
1116
2.470
Why?
Neoplasm Metastasis
27
2024
1108
2.450
Why?
Lung Neoplasms
14
2024
2357
2.170
Why?
Immunotherapy
13
2024
678
1.780
Why?
Radiosurgery
11
2024
288
1.600
Why?
Drug Resistance, Neoplasm
3
2021
617
1.320
Why?
Mucin-1
9
2020
45
1.250
Why?
Combined Modality Therapy
17
2024
1719
1.110
Why?
Radiotherapy
4
2024
331
1.090
Why?
Radioimmunotherapy
4
2024
27
1.080
Why?
Biomarkers, Tumor
8
2024
1548
1.050
Why?
Liver Neoplasms
8
2024
756
1.030
Why?
Small Cell Lung Carcinoma
2
2024
111
0.980
Why?
Aneuploidy
1
2024
57
0.960
Why?
Gene Expression Regulation, Neoplastic
13
2020
1265
0.950
Why?
Neoplasms, Second Primary
2
2022
260
0.870
Why?
Cooperative Behavior
1
2023
179
0.830
Why?
Urinary Bladder
1
2024
246
0.790
Why?
Neoplasm Invasiveness
2
2024
576
0.790
Why?
Urinary Bladder Neoplasms
2
2024
401
0.790
Why?
Humans
79
2024
89222
0.780
Why?
B7-H1 Antigen
3
2024
274
0.770
Why?
Loss of Function Mutation
1
2021
46
0.770
Why?
Patient Care Team
1
2023
283
0.760
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
112
0.750
Why?
Colorectal Neoplasms
6
2023
981
0.680
Why?
Homologous Recombination
2
2017
52
0.670
Why?
Prostatic Neoplasms
6
2024
1769
0.630
Why?
Gene Amplification
1
2018
134
0.600
Why?
Janus Kinase 2
1
2018
60
0.600
Why?
STAT1 Transcription Factor
4
2009
53
0.600
Why?
Pyrrolidines
1
2018
59
0.590
Why?
Anthracyclines
1
2017
38
0.570
Why?
Neoplasm, Residual
2
2017
181
0.540
Why?
Sulfonamides
1
2018
318
0.510
Why?
Breast Neoplasms
7
2017
3003
0.490
Why?
Cell Line, Tumor
16
2024
2553
0.480
Why?
MicroRNAs
5
2023
551
0.470
Why?
Myeloid-Derived Suppressor Cells
2
2024
26
0.460
Why?
Drug Therapy
1
2014
70
0.450
Why?
Tumor Microenvironment
4
2024
461
0.450
Why?
Protein Kinase Inhibitors
1
2018
604
0.450
Why?
Prognosis
10
2021
3779
0.440
Why?
Radiation Tolerance
3
2019
173
0.440
Why?
DNA Repair
2
2022
362
0.440
Why?
Mutation
3
2024
4141
0.440
Why?
Aged
15
2024
19128
0.430
Why?
Radiation, Ionizing
5
2021
121
0.420
Why?
Animals
31
2024
27338
0.380
Why?
Capecitabine
2
2024
98
0.380
Why?
Endothelium, Vascular
1
2012
433
0.360
Why?
Mice
20
2024
11743
0.360
Why?
Neovascularization, Pathologic
1
2012
364
0.350
Why?
Signal Transduction
10
2023
3376
0.350
Why?
Gene Expression Profiling
8
2020
1429
0.340
Why?
Middle Aged
15
2024
25929
0.340
Why?
Antibodies, Monoclonal, Humanized
3
2020
968
0.340
Why?
Metabolic Networks and Pathways
1
2009
81
0.330
Why?
Survival Rate
6
2024
1900
0.330
Why?
Chemoradiotherapy
3
2021
309
0.330
Why?
Male
20
2024
42347
0.320
Why?
Female
21
2024
46118
0.310
Why?
Lipid Metabolism
1
2009
199
0.300
Why?
Energy Metabolism
1
2009
277
0.300
Why?
Antineoplastic Agents
2
2021
2412
0.290
Why?
Gene Regulatory Networks
2
2009
308
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
2563
0.280
Why?
Chromosomes, Human, Pair 14
2
2018
49
0.280
Why?
Inflammation
1
2012
971
0.280
Why?
Aged, 80 and over
7
2024
6799
0.280
Why?
Kaplan-Meier Estimate
4
2018
860
0.270
Why?
Antibodies, Monoclonal
2
2024
1410
0.270
Why?
Neoplasms, Experimental
3
2019
269
0.270
Why?
Neoplasm Staging
5
2024
2011
0.260
Why?
Xenograft Model Antitumor Assays
2
2018
470
0.260
Why?
Androgen Antagonists
2
2024
154
0.260
Why?
Mice, Nude
5
2020
814
0.250
Why?
Genomic Instability
2
2017
80
0.250
Why?
Brain Mapping
1
2008
564
0.250
Why?
DNA Replication
2
2017
170
0.250
Why?
Emotions
1
2008
349
0.240
Why?
5-alpha Reductase Inhibitors
1
2024
12
0.240
Why?
Telomerase
1
2024
62
0.230
Why?
Quality of Life
2
2024
1665
0.230
Why?
Predictive Value of Tests
1
2009
1721
0.230
Why?
Cognition
1
2008
580
0.230
Why?
Gonadotropin-Releasing Hormone
1
2024
108
0.230
Why?
Adult
9
2024
26559
0.220
Why?
Chemical and Drug Induced Liver Injury
1
2024
66
0.220
Why?
Cystectomy
1
2024
110
0.210
Why?
DNA Methylation
2
2018
657
0.210
Why?
Tumor Necrosis Factor-alpha
3
2012
699
0.210
Why?
Radiation Pneumonitis
1
2022
21
0.210
Why?
Interferon Type I
2
2021
178
0.200
Why?
Neoplasm Recurrence, Local
2
2023
1365
0.200
Why?
Follow-Up Studies
4
2024
3661
0.200
Why?
Epigenesis, Genetic
2
2023
507
0.200
Why?
NF-kappa B
2
2023
466
0.200
Why?
Transforming Growth Factor beta
1
2023
321
0.200
Why?
Cisplatin
1
2024
618
0.190
Why?
Light
1
2022
292
0.190
Why?
Cell Proliferation
4
2018
1650
0.190
Why?
Apoptosis
5
2018
1717
0.190
Why?
Retrospective Studies
4
2023
9034
0.190
Why?
Erythroid Precursor Cells
1
2021
33
0.190
Why?
Chemokine CXCL10
2
2024
23
0.190
Why?
Treatment Outcome
8
2024
8227
0.180
Why?
Butyrates
1
2021
46
0.180
Why?
Pneumonia
1
2022
182
0.180
Why?
Tumor Cells, Cultured
3
2018
1057
0.180
Why?
Disease Progression
3
2020
1488
0.180
Why?
Adenocarcinoma
3
2016
1194
0.180
Why?
Cytoreduction Surgical Procedures
1
2020
76
0.180
Why?
Cell Survival
4
2019
982
0.180
Why?
Neuroendocrine Tumors
1
2022
118
0.170
Why?
Carcinoma, Neuroendocrine
1
2020
33
0.170
Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
60
0.170
Why?
Proto-Oncogene Proteins c-myc
2
2020
126
0.170
Why?
DEAD Box Protein 58
2
2016
11
0.170
Why?
Colonic Neoplasms
2
2015
573
0.170
Why?
Oligonucleotide Array Sequence Analysis
2
2012
695
0.160
Why?
Class II Phosphatidylinositol 3-Kinases
1
2018
9
0.160
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
131
0.160
Why?
Carcinoma, Hepatocellular
1
2022
392
0.150
Why?
Proto-Oncogene Proteins
1
2022
665
0.150
Why?
Brain
1
2008
2281
0.150
Why?
Urologic Neoplasms
1
2018
84
0.150
Why?
Interferon-beta
2
2016
126
0.150
Why?
Receptor, Notch1
1
2018
94
0.150
Why?
Neuronal Plasticity
1
2020
193
0.150
Why?
Palliative Care
1
2019
264
0.140
Why?
T-Lymphocytes
2
2021
1224
0.140
Why?
Antimetabolites, Antineoplastic
1
2018
244
0.140
Why?
DNA Damage
2
2017
371
0.140
Why?
Preoperative Period
1
2017
94
0.140
Why?
Adaptive Immunity
3
2024
167
0.140
Why?
DNA Breaks, Double-Stranded
1
2017
66
0.140
Why?
Mice, Inbred C57BL
7
2021
3211
0.140
Why?
Disease Models, Animal
3
2024
2363
0.140
Why?
Prospective Studies
5
2024
4281
0.130
Why?
Pancreatic Neoplasms
1
2022
669
0.130
Why?
Vascular Endothelial Growth Factor A
1
2018
423
0.130
Why?
Biomarkers
1
2022
1764
0.130
Why?
MAP Kinase Kinase Kinases
1
2015
42
0.120
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
164
0.120
Why?
Gene Knockdown Techniques
2
2018
247
0.120
Why?
Gastrointestinal Microbiome
1
2021
505
0.120
Why?
RNA Helicases
1
2014
35
0.110
Why?
Prostate
2
2020
393
0.110
Why?
DEAD-box RNA Helicases
1
2014
64
0.110
Why?
Hospitalization
1
2018
877
0.110
Why?
Human Umbilical Vein Endothelial Cells
1
2012
68
0.100
Why?
rab GTP-Binding Proteins
1
2012
26
0.100
Why?
Stress, Physiological
1
2014
232
0.100
Why?
Heterografts
3
2018
102
0.100
Why?
Ipilimumab
2
2022
61
0.100
Why?
Endothelial Cells
2
2012
459
0.100
Why?
Antineoplastic Agents, Hormonal
2
2024
157
0.100
Why?
Estrogen Receptor alpha
2
2012
147
0.100
Why?
Transcriptional Activation
2
2012
292
0.100
Why?
Myeloid Cells
2
2023
100
0.100
Why?
Melanoma, Experimental
2
2009
104
0.100
Why?
RNA-Binding Proteins
2
2023
259
0.090
Why?
Diagnostic Imaging
1
2015
479
0.090
Why?
Interferon-gamma
4
2019
451
0.090
Why?
Receptors, Estrogen
1
2012
393
0.090
Why?
Glioma
1
2012
293
0.090
Why?
Multivariate Analysis
1
2012
988
0.090
Why?
Epithelial-Mesenchymal Transition
2
2023
96
0.090
Why?
Tumor Burden
2
2024
308
0.080
Why?
Tandem Mass Spectrometry
1
2009
104
0.080
Why?
Immunity, Innate
2
2024
429
0.080
Why?
X-Ray Therapy
1
2008
6
0.080
Why?
Interleukins
1
2009
129
0.080
Why?
Proteome
1
2009
132
0.080
Why?
Radiation-Sensitizing Agents
1
2008
97
0.080
Why?
Magnetic Resonance Imaging
2
2012
3444
0.080
Why?
DNA (Cytosine-5-)-Methyltransferase 1
2
2018
20
0.080
Why?
HCT116 Cells
2
2018
155
0.070
Why?
MCF-7 Cells
2
2018
114
0.070
Why?
Neoplasm Transplantation
3
2016
397
0.070
Why?
Cells, Cultured
1
2012
2880
0.070
Why?
Cholesterol
1
2009
358
0.070
Why?
Antineoplastic Agents, Immunological
2
2020
195
0.070
Why?
Genetic Therapy
1
2008
370
0.070
Why?
Mice, Knockout
3
2019
1990
0.070
Why?
CD8-Positive T-Lymphocytes
1
2010
595
0.070
Why?
Recurrence
1
2009
1143
0.070
Why?
Neoplasm Proteins
1
2009
540
0.060
Why?
Mice, SCID
2
2016
261
0.060
Why?
Leuprolide
1
2024
35
0.060
Why?
Etoposide
1
2024
206
0.060
Why?
CTLA-4 Antigen
1
2024
139
0.060
Why?
Cell Movement
2
2019
783
0.060
Why?
Mice, Transgenic
2
2019
1574
0.060
Why?
Carboplatin
1
2024
312
0.060
Why?
Proportional Hazards Models
2
2016
848
0.050
Why?
Clinical Trials, Phase I as Topic
1
2024
156
0.050
Why?
Methylation
1
2023
268
0.050
Why?
Programmed Cell Death 1 Receptor
1
2024
171
0.050
Why?
Poly(ADP-ribose) Polymerases
1
2022
51
0.050
Why?
Fluorouracil
1
2023
561
0.050
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2022
77
0.050
Why?
Metastasectomy
1
2020
9
0.050
Why?
Vancomycin
1
2021
73
0.050
Why?
Synaptophysin
1
2020
11
0.040
Why?
POU Domain Factors
1
2020
8
0.040
Why?
Aurora Kinase A
1
2020
11
0.040
Why?
Octamer Transcription Factor-3
1
2020
16
0.040
Why?
SOXB1 Transcription Factors
1
2020
21
0.040
Why?
N-Myc Proto-Oncogene Protein
1
2020
38
0.040
Why?
Enhancer of Zeste Homolog 2 Protein
1
2020
37
0.040
Why?
RNA
1
2023
578
0.040
Why?
Kruppel-Like Transcription Factors
1
2020
100
0.040
Why?
Administration, Oral
1
2021
682
0.040
Why?
Rats
3
2010
4041
0.040
Why?
Gastrointestinal Tract
1
2021
191
0.040
Why?
Receptors, Tumor Necrosis Factor
2
2009
90
0.040
Why?
Feasibility Studies
1
2021
780
0.040
Why?
Cell Line
2
2016
2495
0.040
Why?
Clinical Trials, Phase III as Topic
1
2019
175
0.040
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2020
170
0.040
Why?
Molecular Targeted Therapy
1
2020
285
0.040
Why?
Clinical Trials, Phase II as Topic
1
2019
172
0.040
Why?
Neoplastic Stem Cells
1
2020
161
0.040
Why?
Prostatic Neoplasms, Castration-Resistant
1
2020
121
0.040
Why?
Response Evaluation Criteria in Solid Tumors
1
2018
58
0.040
Why?
Azacitidine
1
2018
147
0.040
Why?
Dose-Response Relationship, Radiation
1
2018
188
0.040
Why?
Nerve Tissue Proteins
1
2021
511
0.040
Why?
Carcinogenesis
1
2020
211
0.040
Why?
Promoter Regions, Genetic
2
2012
956
0.040
Why?
Clinical Decision-Making
1
2020
280
0.040
Why?
RNA, Long Noncoding
1
2018
117
0.040
Why?
Comorbidity
1
2021
948
0.040
Why?
Membrane Proteins
1
2023
1216
0.040
Why?
Tumor Suppressor Protein p53
1
2020
414
0.040
Why?
cdc25 Phosphatases
1
2016
19
0.040
Why?
Bacteria
1
2021
475
0.040
Why?
Radiotherapy Dosage
1
2018
470
0.030
Why?
Remission Induction
1
2018
740
0.030
Why?
Transcription Factor RelA
1
2016
49
0.030
Why?
RNA, Small Untranslated
1
2016
15
0.030
Why?
Transcriptome
1
2021
628
0.030
Why?
E1A-Associated p300 Protein
1
2016
14
0.030
Why?
Patient Safety
1
2018
217
0.030
Why?
Medical Oncology
1
2020
383
0.030
Why?
Homeodomain Proteins
1
2020
556
0.030
Why?
Phenotype
2
2015
2439
0.030
Why?
Transcription Factors
1
2023
1652
0.030
Why?
Receptors, CXCR3
1
2015
12
0.030
Why?
Wnt Proteins
1
2016
130
0.030
Why?
Survival Analysis
1
2019
1534
0.030
Why?
Luminescent Measurements
1
2015
62
0.030
Why?
Clinical Trials as Topic
1
2020
1151
0.030
Why?
Randomized Controlled Trials as Topic
1
2019
835
0.030
Why?
Immunoprecipitation
1
2015
138
0.030
Why?
Flow Cytometry
1
2016
691
0.030
Why?
Chromatin Immunoprecipitation
1
2015
136
0.030
Why?
Mice, Inbred NOD
1
2015
195
0.030
Why?
Gene Expression Regulation
1
2023
1975
0.030
Why?
Immunoblotting
1
2015
273
0.030
Why?
Transcription, Genetic
2
2009
1157
0.030
Why?
beta Catenin
1
2016
266
0.030
Why?
Biopsy
1
2018
1183
0.030
Why?
RNA, Small Interfering
1
2016
557
0.030
Why?
HEK293 Cells
1
2016
639
0.030
Why?
Polymerase Chain Reaction
1
2015
922
0.030
Why?
Imaging, Three-Dimensional
1
2016
596
0.030
Why?
Peptides
1
2016
648
0.030
Why?
Spheroids, Cellular
1
2012
31
0.030
Why?
Risk Assessment
1
2020
2301
0.030
Why?
Estradiol
1
2012
250
0.020
Why?
Glioblastoma
1
2014
265
0.020
Why?
Time Factors
1
2020
5336
0.020
Why?
Salvage Therapy
1
2012
236
0.020
Why?
Neoplasm Grading
1
2012
374
0.020
Why?
Gene Expression
1
2015
1310
0.020
Why?
Cell Differentiation
1
2016
1521
0.020
Why?
Prostate-Specific Antigen
1
2012
360
0.020
Why?
Tomography, X-Ray Computed
1
2020
2659
0.020
Why?
Mammary Glands, Human
1
2009
24
0.020
Why?
Mice, Mutant Strains
1
2010
231
0.020
Why?
Cytotoxins
1
2009
16
0.020
Why?
Infant
1
2016
3152
0.020
Why?
Interleukin-8
1
2009
86
0.020
Why?
Receptors, Tumor Necrosis Factor, Type II
1
2008
20
0.020
Why?
Child, Preschool
1
2016
3724
0.020
Why?
Etanercept
1
2008
33
0.020
Why?
Cytoplasm
1
2009
284
0.020
Why?
Caspases
1
2009
155
0.020
Why?
Coculture Techniques
1
2009
173
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2008
43
0.020
Why?
Adenoviridae
1
2010
349
0.020
Why?
Prostatectomy
1
2012
477
0.020
Why?
Protein Binding
1
2012
1487
0.020
Why?
Genetic Vectors
1
2010
446
0.020
Why?
Patient Selection
1
2012
684
0.020
Why?
Doxorubicin
1
2009
298
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
887
0.020
Why?
Brain Neoplasms
1
2014
781
0.020
Why?
Interleukin-6
1
2009
261
0.020
Why?
Transplantation, Heterologous
1
2009
370
0.020
Why?
Protein Structure, Tertiary
1
2009
740
0.020
Why?
Transfection
1
2009
911
0.020
Why?
Lymphocyte Activation
1
2010
751
0.020
Why?
Immunoglobulin G
1
2008
465
0.020
Why?
Cell Transformation, Neoplastic
1
2009
447
0.020
Why?
Disease-Free Survival
1
2009
1214
0.020
Why?
Fibroblasts
1
2009
755
0.020
Why?
Amino Acid Sequence
1
2009
2062
0.020
Why?
Cytokines
1
2009
802
0.020
Why?
Molecular Sequence Data
1
2009
3027
0.020
Why?
Child
1
2016
7158
0.020
Why?
Immunosuppressive Agents
1
2008
975
0.010
Why?
Lung
1
2009
1259
0.010
Why?
Pitroda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (317)
Explore
_
Co-Authors (87)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_